The neural crest in cardiac congenital anomalies

Differentiation

Volumn 84, Issue 1, 2012, Pages 25-40

  Keyte, Anna ^a   Hutson, Mary Redmond ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aortic arch arteries; Cardiac neural crest; Congentital heart defects; DiGeorge syndrome; Persistent truncus arteriosus; Second heart field

Indexed keywords

3 [4 METHYL 2 (2 OXO 3 INDOLINYLMETHYLIDENYL) 3 PYRROLYL]PROPIONIC ACID; ALCOHOL; BONE MORPHOGENETIC PROTEIN; CHEMOTACTIC FACTOR; CRK LIKE PROTEIN; ENDOTHELIN; FIBROBLAST GROWTH FACTOR 8; FORKHEAD TRANSCRIPTION FACTOR; ISOTRETINOIN; JAGGED1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROPILIN 1; NOTCH2 RECEPTOR; PROTEIN TYROSINE PHOSPHATASE SHP 2; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR BETA; RETINOID X RECEPTOR; RETINOL; RETINOL BINDING PROTEIN; SEMAPHORIN 3C; SOS PROTEIN; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR PAX3; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACNE; ALAGILLE SYNDROME; AORTA ARCH; CELL MIGRATION; CHROMOSOME DELETION 22Q11; CONGENITAL HEART MALFORMATION; DIGEORGE SYNDROME; DRUG EFFECT; EMBRYO PATTERN FORMATION; FETAL ALCOHOL SYNDROME; GENE DISRUPTION; HEART CONDUCTION; HEART DEVELOPMENT; HEART INNERVATION; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART VALVE; HUMAN; LEOPARD SYNDROME; NEURAL CREST; NEURAL CREST CELL; NONHUMAN; NOONAN SYNDROME; PATHOGENESIS; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RETINOIC ACID SYNDROME; REVIEW; SIGNAL TRANSDUCTION; SYNDROME CHARGE; TERATOGENICITY; VELOCARDIOFACIAL SYNDROME; WAARDENBURG SYNDROME;

ABNORMALITIES, MULTIPLE; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CRANIOFACIAL ABNORMALITIES; DISEASE MODELS, ANIMAL; HEART; HEART DEFECTS, CONGENITAL; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MICE; MYOCYTES, CARDIAC; NEURAL CREST; NEURONS; SYNDROME;

EID: 84863086848     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2012.04.005     Document Type: Review

References (201)

1. Abu-Issa R., Smyth G., Smoak I., Yamamura K.-i., Meyers E.N. Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. Development (Cambridge, England) 2002, 129:4613-4625.
2. Aggarwal V.S., Morrow B.E. Genetic modifiers of the physical malformations in velo-cardio-facial syndrome/DiGeorge syndrome. Developmental Disabilities Research Reviews 2008, 14:19-25.
3. Amati F., Conti E., Novelli A., Bengala M., Diglio M.C., Marino B., Giannotti A., Gabrielli O., Novelli G., Dallapiccola B. Atypical deletions suggest five 22q11.2 critical regions related to the DiGeorge/velo-cardio-facial syndrome. European Journal of Human Genetics: EJHG 1999, 7:903-909.
4. Araki T., Chan G., Newbigging S., Morikawa L., Bronson R.T., Neel B.G. Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation. Proceedings of the National academy of Sciences of the United States of America 2009, 106:4736-4741.
5. Bajpai R., Chen D.A., Rada-Iglesias A., Zhang J., Xiong Y., Helms J., Chang C.-P., Zhao Y., Swigut T., Wysocka J. CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature 2010, 463:958-962.
6. Ballard V.L.T., Mikawa T. Constitutive expression of preproendothelin in the cardiac neural crest selectively promotes expansion of the adventitia of the great vessels in vivo. Developmental Biology 251 2002, 167-177.
7. Banerjee A.K. Waardenburg's syndrome associated with ostium secundum atrial septal defect. Journal of the Royal Society of Medicine 1986, 79:677-678.
8. Bergman J.E.H., Janssen N., Hoefsloot L.H., Jongmans M.C.J., Hofstra R.M.W., van Ravenswaaij-Arts C.M.A. CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype. Journal of Medical Genetics 2011, 48:334-342.
9. Bergwerff M., Verberne M.E., DeRuiter M.C., Poelmann R.E., Gittenberger-de Groot A.C. Neural crest cell contribution to the developing circulatory system: implications for vascular morphology?. Circulation Research 1998, 82:221-231.
10. Besson W.T., Kirby M.L., Van Mierop L.H., Teabeaut J.R. Effects of the size of lesions of the cardiac neural crest at various embryonic ages on incidence and type of cardiac defects. Circulation 1986, 73:360-364.
11. Bockman D.E., Redmond M.E., Waldo K., Davis H., Kirby M.L. Effect of neural crest ablation on development of the heart and arch arteries in the chick. The American Journal of Anatomy 1987, 180:332-341.
12. Böttcher R.T., Niehrs C. Fibroblast growth factor signaling during early vertebrate development. Endocrine Reviews 2005, 26:63-77.
13. Botto L.D., Loffredo C., Scanlon K.S., Ferencz C., Khoury M.J., David Wilson P., Correa A. Vitamin A and cardiac outflow tract defects. Epidemiology 2001, 12:491-496.
14. Brown C.B., Feiner L., Lu M.M., Li J., Ma X., Webber A.L., Jia L., Raper J.A., Epstein J.A. PlexinA2 and semaphorin signaling during cardiac neural crest development. Development (Cambridge, England) 2001, 128:3071-3080.
15. Burch M., Sharland M., Shinebourne E., Smith G., Patton M., McKenna W. Cardiologic abnormalities in Noonan syndrome: phenotypic diagnosis and echocardiographic assessment of 118 patients. Journal of the American College of Cardiology 1993, 22:1189-1192.
16. Calmont A., Ivins S., Van Bueren K.L., Papangeli I., Kyriakopoulou V., Andrews W.D., Martin J.F., Moon A.M., Illingworth E.A., Basson M.A., Scambler P.J. Tbx1 controls cardiac neural crest cell migration during arch artery development by regulating Gbx2 expression in the pharyngeal ectoderm. Development (Cambridge, England) 2009, 136:3173-3183.
17. Carmichael S.L., Shaw G.M., Yang W., Lammer E.J. Maternal periconceptional alcohol consumption and risk for conotruncal heart defects. Birth Defects Research Part A Clinical and Molecular Teratology 2003, 67:875-878.
18. Chapnik, E., Sasson, V., Blelloch, R., Hornstein, E., 2011. Dgcr8 controls neural crest cells survival in cardiovascular development. Developmental Biology.
19. Chen J.Y., Clifford J., Zusi C., Starrett J., Tortolani D., Ostrowski J., Reczek P.R., Chambon P., Gronemeyer H. Two distinct actions of retinoid-receptor ligands. Nature 1996, 382:819-822.
20. Chen Q., Chen H., Zheng D., Kuang C., Fang H., Zou B., Zhu W., Bu G., Jin T., Wang Z., Zhang X., Chen J., Field L.J., Rubart M., Shou W., Chen Y. Smad7 is required for the development and function of the heart. Journal of Biological Chemistry 2009, 284:292-300.
21. Chen S.Y., Yang B., Jacobson K., Sulik K.K. The membrane disordering effect of ethanol on neural crest cells in vitro and the protective role of GM1 ganglioside. Alcohol 1996, 13:589-595.
22. Chisaka O., Capecchi M.R. Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5. Nature 1991, 350:473-479.
23. Choi M., Klingensmith J. Chordin is a modifier of tbx1 for the craniofacial malformations of 22q11 deletion syndrome phenotypes in mouse. PLoS Genetics 2009, 5:e1000395.
24. Clouthier D.E., Hosoda K., Richardson J.A., Williams S.C., Yanagisawa H., Kuwaki T., Kumada M., Hammer R.E., Yanagisawa M. Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development (Cambridge, England) 1998, 125:813-824.
25. Clouthier D.E., Williams S.C., Hammer R.E., Richardson J.A., Yanagisawa M. Cell-autonomous and nonautonomous actions of endothelin-A receptor signaling in craniofacial and cardiovascular development. Developmental Biology 2003, 261:506-519.
26. Coberly S., Lammer E., Alashari M. Retinoic acid embryopathy: case report and review of literature. Pediatrics Pathology & Laboratory Medicine 1996, 16:823-836.
27. Conway S.J., Bundy J., Chen J., Dickman E., Rogers R., Will B.M. Decreased neural crest stem cell expansion is responsible for the conotruncal heart defects within the splotch (Sp(2H))/Pax3 mouse mutant. Cardiovascular Research 2000, 47:314-328.
28. Conway S.J., Godt R.E., Hatcher C.J., Leatherbury L., Zolotouchnikov V.V., Brotto M.A., Copp A.J., Kirby M.L., Creazzo T.L. Neural crest is involved in development of abnormal myocardial function. Journal of Molecular Cell Cardiology 1997, 29:2675-2685.
29. Conway S.J., Henderson D.J., Copp A.J. Pax3 is required for cardiac neural crest migration in the mouse: evidence from the splotch (Sp2H) mutant. Development (Cambridge, England) 1997, 124:505-514.
30. Conway S.J., Henderson D.J., Kirby M.L., Anderson R.H., Copp A.J. Development of a lethal congenital heart defect in the splotch (Pax3) mutant mouse. Cardiovascular Research 1997, 36:163-173.
31. Corson L.B., Yamanaka Y., Lai K.-M.V., Rossant J. Spatial and temporal patterns of ERK signaling during mouse embryogenesis. Development (Cambridge, England) 2003, 130:4527-4537.
32. Creazzo T.L., Brotto M.A., Burch J. Excitation-contraction coupling in the day 15 embryonic chick heart with persistent truncus arteriosus. Pediatrics Research 1997, 42:731-737.
33. Creazzo T.L., Godt R.E., Leatherbury L., Conway S.J., Kirby M.L. Role of cardiac neural crest cells in cardiovascular development. Annual Review of Physiology 1998, 60:267-286.
34. de Lange F.J., Moorman A.F.M., Anderson R.H., Männer J., Soufan A.T., de Gier-de Vries C., Schneider M.D., Webb S., van den Hoff M.J.B., Christoffels V.M. Lineage and morphogenetic analysis of the cardiac valves. Circulation Research 2004, 95:645-654.
35. Digilio M.C., Conti E., Sarkozy A., Mingarelli R., Dottorini T., Marino B., Pizzuti A., Dallapiccola B. Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. American Journal of Human Genetics 2002, 71:389-394.
36. Diman N.Y.S.-G., Remacle S., Bertrand N., Picard J.J., Zaffran S., Rezsohazy R. A retinoic Acid responsive hoxa3 transgene expressed in embryonic pharyngeal endoderm, cardiac neural crest and a subdomain of the second heart field. PLoS One 2011, 6:e27624.
37. Dollé P., Fraulob V., Gallego-Llamas J., Vermot J., Niederreither K. Fate of retinoic acid-activated embryonic cell lineages. Developmental Dynamics 2010, 239:3260-3274.
38. Dunty W.C., Chen S.Y., Zucker R.M., Dehart D.B., Sulik K.K. Selective vulnerability of embryonic cell populations to ethanol-induced apoptosis: implications for alcohol-related birth defects and neurodevelopmental disorder. Alcoholism: Clinical & Experimental Research 2001, 25:1523-1535.
39. Dyer L.A., Kirby M.L. The role of secondary heart field in cardiac development. Developmental Biology 2009, 336:137-144.
40. Edouard T., Combier J.-P., Nédélec A., Bel-Vialar S., Métrich M., Conte-Auriol F., Lyonnet S., Parfait B., Tauber M., Salles J.-P., Lezoualc'h F., Yart A., Raynal P. Functional effects of PTPN11 (SHP2) mutations causing LEOPARD syndrome on epidermal growth factor-induced phosphoinositide 3-kinase/AKT/glycogen synthase kinase 3beta signaling. Molecular and Cell Biology 2010, 30:2498-2507.
41. Edouard T., Montagner A., Dance M., Conte F., Yart A., Parfait B., Tauber M., Salles J.P., Raynal P. How do Shp2 mutations that oppositely influence its biochemical activity result in syndromes with overlapping symptoms?. Cellular and Molecular Life Sciences 2007, 64:1585-1590.
42. Eldadah Z.A., Hamosh A., Biery N.J., Montgomery R.A., Duke M., Elkins R., Dietz H.C. Familial tetralogy of Fallot caused by mutation in the jagged1 gene. Human Molecular Genetics 2001, 10:163-169.
43. Fang J., Dagenais S.L., Erickson R.P., Arlt M.F., Glynn M.W., Gorski J.L., Seaver L.H., Glover T.W. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. American Journal of Human Genetics 2000, 67:1382-1388.
44. Farrell M.J., Burch J.L., Wallis K., Rowley L., Kumiski D., Stadt H., Godt R.E., Creazzo T.L., Kirby M.L. FGF-8 in the ventral pharynx alters development of myocardial calcium transients after neural crest ablation. Journal of Clinical Investigation 2001, 107:1509-1517.
45. Farrell M.J., Stadt H., Wallis K.T., Scambler P., Hixon R.L., Wolfe R., Leatherbury L., Kirby M.L. HIRA, a DiGeorge syndrome candidate gene, is required for cardiac outflow tract septation. Circulation Research 1999, 84:127-135.
46. Feiner L., Webber A.L., Brown C.B., Lu M.M., Jia L., Feinstein P., Mombaerts P., Epstein J.A., Raper J.A. Targeted disruption of semaphorin 3C leads to persistent truncus arteriosus and aortic arch interruption. Development (Cambridge, England) 2001, 128:3061-3070.
47. Flentke G.R., Garic A., Amberger E., Hernandez M., Smith S.M. Calcium-mediated repression of Β-catenin and its transcriptional signaling mediates neural crest cell death in an avian model of fetal alcohol syndrome. Birth Defects Research Part A Clinical and Molecular Teratology 2011, 91:591-602.
48. Fragale A., Tartaglia M., Wu J., Gelb B.D. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation. Human Mutation 2004, 23:267-277.
49. Frank D., Fotheringham L., Brewer J., Muglia L., Tristani-Firouzi M., Capecchi M., Moon A. An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome. Development (Cambridge, England) 2002, 129:4591-4603.
50. Garg V., Yamagishi C., Hu T., Kathiriya I.S., Yamagishi H., Srivastava D. Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog during pharyngeal arch development. Developmental Biology 2001, 235:62-73.
51. Ghyselinck N.B., Wendling O., Messaddeq N., Dierich A., Lampron C., Decimo D., Viville S., Chambon P., Mark M. Contribution of retinoic acid receptor beta isoforms to the formation of the conotruncal septum of the embryonic heart. Developmental Biology 1998, 198:303-318.
52. Goodship J., Cross I., Scambler P., Burn J. Monozygotic twins with chromosome 22q11 deletion and discordant phenotype. Journal of Medical Genetics 1995, 32:746-748.
53. Gorlin R.J., Anderson R.C., Moller J.H. The LEOPARD (multiple lentigines) syndrome revisited. Birth Defects Origins Article Series 1971, 07:110-115.
54. Gu C., Yoshida Y., Livet J., Reimert D., Mann F., Merte J., Henderson C., Jessell T., Kolodkin A., Ginty D. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science (New York, N.Y 2005, 307:265-268.
55. Guris D.L., Duester G., Papaioannou V.E., Imamoto A. Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome. Developmental Cell 10 2006, 81-92.
56. Guris D.L., Fantes J., Tara D., Druker B.J., Imamoto A. Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nature Genetics 2001, 27:293-298.
57. Gurjarpadhye A., Hewett K.W., Justus C., Wen X., Stadt H., Kirby M.L., Sedmera D., Gourdie R.G. Cardiac neural crest ablation inhibits compaction and electrical function of conduction system bundles. American Journal of Physiology-Heart and Circulatory Physiology 2007, 292:H1291-H1300.
58. Hassler J.A., Moran D.J. Effects of ethanol on the cytoskeleton of migrating and differentiating neural crest cells: possible role in teratogenesis. Journal of Craniofacial Genetics and Developmental Biology-Supplement 1986, 2:129-136.
59. Hierck B.P., Molin D.G.M., Boot M.J., Poelmann R.E., Gittenberger-de Groot A.C. A chicken model for DGCR6 as a modifier gene in the DiGeorge critical region. Pediatrics Research 2004, 56:440-448.
60. High F.A., Jain R., Stoller J.Z., Antonucci N.B., Lu M.M., Loomes K.M., Kaestner K.H., Pear W.S., Epstein J.A. Murine Jagged1/Notch signaling in the second heart field orchestrates Fgf8 expression and tissue-tissue interactions during outflow tract development. Journal of Clinical Investigation 2009, 119:1986-1996.
61. High F.A., Zhang M., Proweller A., Tu L., Parmacek M.S., Pear W.S., Epstein J.A. An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation. Journal of Clinical Investigation 2007, 117:353-363.
62. Hofstra R.M., Valdenaire O., Arch E., Osinga J., Kroes H., Löffler B.M., Hamosh A., Meijers C., Buys C.H. A loss-of-function mutation in the endothelin-converting enzyme 1 (ECE-1) associated with Hirschsprung disease, cardiac defects, and autonomic dysfunction. American Journal of Human Genetics 1999, 64:304-308.
63. Honkanen R.A., Nishimura D.Y., Swiderski R.E., Bennett S.R., Hong S., Kwon Y.H., Stone E.M., Sheffield V.C., Alward W.L.M. A family with Axenfeld-Rieger syndrome and Peters Anomaly caused by a point mutation (Phe112Ser) in the FOXC1 gene. American Journal of Ophthalmology 2003, 135:368-375.
64. Hu T., Yamagishi H., Maeda J., McAnally J., Yamagishi C., Srivastava D. Tbx1 regulates fibroblast growth factors in the anterior heart field through a reinforcing autoregulatory loop involving forkhead transcription factors. Development (Cambridge, England) 2004, 131:5491-5502.
65. Hutson M.R., Kirby M.L. Neural crest and cardiovascular development: a 20-year perspective. Birth Defects Research Part C: Embryo Today 2003, 69:2-13.
66. Hutson M.R., Zhang P., Stadt H.A., Sato A.K., Li Y.-X., Burch J., Creazzo T.L., Kirby M.L. Cardiac arterial pole alignment is sensitive to FGF8 signaling in the pharynx. Developmental Biology 2006, 295:486-497.
67. Iida K., Koseki H., Kakinuma H., Kato N., Mizutani-Koseki Y., Ohuchi H., Yoshioka H., Noji S., Kawamura K., Kataoka Y., Ueno F., Taniguchi M., Yoshida N., Sugiyama T., Miura N. Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development (Cambridge, England) 1997, 124:4627-4638.
68. Ivins S., Lammerts van Beuren K., Roberts C., James C., Lindsay E., Baldini A., Ataliotis P., Scambler P.J. Microarray analysis detects differentially expressed genes in the pharyngeal region of mice lacking Tbx1. Developmental Biology 2005, 285:554-569.
69. Jain R., Engleka K.A., Rentschler S.L., Manderfield L.J., Li L., Yuan L., Epstein J.A. Cardiac neural crest orchestrates remodeling and functional maturation of mouse semilunar valves. Journal of Clinical Investigation 2011, 121:422-430.
70. Jenkins K.J., Correa A., Feinstein J.A., Botto L., Britt A.E., Daniels S.R., Elixson M., Warnes C.A., Webb C.L., Young A.H.A.C.o.C.D.i.t Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007, 115:2995-3014.
71. Jerome L.A., Papaioannou V.E. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nature Genetics 2001, 27:286-291.
72. Jiang X., Choudhary B., Merki E., Chien K.R., Maxson R.E., Sucov H.M. Normal fate and altered function of the cardiac neural crest cell lineage in retinoic acid receptor mutant embryos. Mechanisms of Development 2002, 117:115-122.
73. Jiang X., Rowitch D.H., Soriano P., McMahon A.P., Sucov H.M. Fate of the mammalian cardiac neural crest. Development (Cambridge, England) 2000, 127:1607-1616.
74. Jones K.L. The effects of alcohol on fetal development. Birth Defects Research Part C 2011, 93:3-11.
75. Kaartinen V., Dudas M., Nagy A., Sridurongrit S., Lu M.M., Epstein J.A. Cardiac outflow tract defects in mice lacking ALK2 in neural crest cells. Development (Cambridge, England) 2004, 131:3481-3490.
76. Kamath B.M., Krantz I.D., Spinner N.B., Heubi J.E., Piccoli D.A. Monozygotic twins with a severe form of Alagille syndrome and phenotypic discordance. American Journal of Medical Genetics 2002, 112:194-197.
77. Kawaguchi R., Yu J., Honda J., Hu J., Whitelegge J., Ping P., Wiita P., Bok D., Sun H. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science (New York, N.Y 2007, 315:820-825.
78. Kawasaki T., Kitsukawa T., Bekku Y., Matsuda Y., Sanbo M., Yagi T., Fujisawa H. A requirement for neuropilin-1 in embryonic vessel formation. Development (Cambridge, England) 1999, 126:4895-4902.
79. Keilhack H., David F.S., McGregor M., Cantley L.C., Neel B.G. Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes. The Journal of Biological Chemistry 2005, 280:30984-30993.
80. Khaldi F., Serbegi M., Mokadem H., Lazzem B., Bennaceur B. [Waardenburg syndrome. Report of a familial case]. Annals of Pediatric Cardiology (Paris) 1990, 37:55-58.
81. Kirby M.L. Cardiac Development 2006, Oxford University Press, Oxford, UK.
82. Kirby M.L., Gale T.F., Stewart D.E. Neural crest cells contribute to normal aorticopulmonary septation. Science (New York, N.Y 1983, 220:1059-1061.
83. Kirby M.L., Hunt P., Wallis K., Thorogood P. Abnormal patterning of the aortic arch arteries does not evoke cardiac malformations. Developmental Dynamics 1997, 208:34-47.
84. Kirby M.L., Hutson M.R. Role of cardiac neural crest in the development of the caudal pharyngeal arches, the cardiac outflow and disease. Heart Development and Regeneration 2010, 441-462. Academic Press, London. N. Rosenthal, R.P. Harvey (Eds.).
85. Kitajima S., Miyagawa-Tomita S., Inoue T., Kanno J., Saga Y. Mesp1-nonexpressing cells contribute to the ventricular cardiac conduction system. Developmental Dynamics 2006, 235:395-402.
86. Kochilas L., Merscher-Gomez S., Lu M.M., Potluri V., Liao J., Kucherlapati R., Morrow B., Epstein J.A. The role of neural crest during cardiac development in a mouse model of DiGeorge syndrome. Developmental Biology 2002, 251:157-166.
87. Kodo K., Nishizawa T., Furutani M., Arai S., Yamamura E., Joo K., Takahashi T., Matsuoka R., Yamagishi H. GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling. Proceedings of the National academy of Sciences of the United States of America 2009, 106:13933-13938.
88. Kontaridis M.I., Swanson K.D., David F.S., Barford D., Neel B.G. PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects. Journal of Biological Chemistry 2006, 281:6785-6792.
89. Koudova M., Seemanova E., Zenker M. Novel BRAF mutation in a patient with LEOPARD syndrome and normal intelligence. European Journal of Medical Genetics 2009, 52:337-340.
90. Krantz I.D., Smith R., Colliton R.P., Tinkel H., Zackai E.H., Piccoli D.A., Goldmuntz E., Spinner N.B. Jagged1 mutations in patients ascertained with isolated congenital heart defects. American Journal of Medical Genetics 1999, 84:56-60.
91. Kubalak S.W., Hutson D.R., Scott K.K., Shannon R.A. Elevated transforming growth factor beta2 enhances apoptosis and contributes to abnormal outflow tract and aortic sac development in retinoic X receptor alpha knockout embryos. Development (Cambridge, England) 2002, 129:733-746.
92. Kume T., Jiang H., Topczewska J.M., Hogan B.L. The murine winged helix transcription factors, Foxc1 and Foxc2, are both required for cardiovascular development and somitogenesis. Genes & Development 2001, 15:2470-2482.
93. Kurihara Y., Kurihara H., Suzuki H., Kodama T., Maemura K., Nagai R., Oda H., Kuwaki T., Cao W.H., Kamada N. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 1994, 368:703-710.
94. Lalani S., Safiullah A., Molinari L., Fernbach S., Martin D., Belmont J. SEMA3E mutation in a patient with CHARGE syndrome. Journal of Medical Genetics 2004, 41:e94.
95. Lammer E.J., Chen D.T., Hoar R.M., Agnish N.D., Benke P.J., Braun J.T., Curry C.J., Fernhoff P.M., Grix A.W., Lott I.T. Retinoic acid embryopathy. New England Journal of Medicine 1985, 313:837-841.
96. Layman W.S., Hurd E.A., Martin D.M. Chromodomain proteins in development: lessons from CHARGE syndrome. Clinical Genetics 2010, 78:11-20.
97. Le Douarin N.M. The Neural Crest 1982, Cambride University Press, Cambridge. 1st edn.
98. Leatherbury L., Connuck D.M., Gauldin H.E., Kirby M.L. Hemodynamic changes and compensatory mechanisms during early cardiogenesis after neural crest ablation in chick embryos. Pediatrics Research 1991, 30:509-512.
99. Leatherbury L., Gauldin H.E., Waldo K., Kirby M.L. Microcinephotography of the developing heart in neural crest-ablated chick embryos. Circulation 1990, 81:1047-1057.
100. Lee M., Brennan A., Blanchard A., Zoidl G., Dong Z., Tabernero A., Zoidl C., Dent M.A., Jessen K.R., Mirsky R. P0 is constitutively expressed in the rat neural crest and embryonic nerves and is negatively and positively regulated by axons to generate non-myelin-forming and myelin-forming Schwann cells, respectively. Molecular and Cell Neuroscience 1997, 8:336-350.
101. Legius E., Schrander-Stumpel C., Schollen E., Pulles-Heintzberger C., Gewillig M., Fryns J.-P. PTPN11 mutations in LEOPARD syndrome. Journal of Medical Genetics 2002, 39:571-574.
102. Lepore J.J., Mericko P.A., Cheng L., Lu M.M., Morrisey E.E., Parmacek M.S. GATA-6 regulates semaphorin 3C and is required in cardiac neural crest for cardiovascular morphogenesis. Journal of Clinical Investigation 2006, 116:929-939.
103. Li P., Pashmforoush M., Sucov H.M. Retinoic acid regulates differentiation of the secondary heart field and TGFbeta-mediated outflow tract septation. Developmental Cell 18 2010, 480-485.
104. Liao J., Aggarwal V.S., Nowotschin S., Bondarev A., Lipner S., Morrow B.E. Identification of downstream genetic pathways of Tbx1 in the second heart field. Developmental Biology 2008, 316:524-537.
105. Lindsay E.A., Botta A., Jurecic V., Carattini-Rivera S., Cheah Y.C., Rosenblatt H.M., Bradley A., Baldini A. Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 1999, 401:379-383.
106. Lindsay E.A., Vitelli F., Su H., Morishima M., Huynh T., Pramparo T., Jurecic V., Ogunrinu G., Sutherland H.F., Scambler P.J., Bradley A., Baldini A. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 2001, 410:97-101.
107. Liu Y., Xiao A. Epigenetic regulation in neural crest development. Birth Defects Research Part A Clinical and Molecular Teratology 2011, 91:788-796.
108. Loomes K.M., Taichman D.B., Glover C.L., Williams P.T., Markowitz J.E., Piccoli D.A., Baldwin H.S., Oakey R.J. Characterization of Notch receptor expression in the developing mammalian heart and liver. American Journal of Medical Genetics 2002, 112:181-189.
109. Lu H.C., Eichele G., Thaller C. Ligand-bound RXR can mediate retinoid signal transduction during embryogenesis. Development (Cambridge, England) 1997, 124:195-203.
110. Macatee T.L., Hammond B.P., Arenkiel B.R., Francis L., Frank D.U., Moon A.M. Ablation of specific expression domains reveals discrete functions of ectoderm- and endoderm-derived FGF8 during cardiovascular and pharyngeal development. Development (Cambridge, England) 2003, 130:6361-6374.
111. Marino B., Digilio M.C., Toscano A., Giannotti A., Dallapiccola B. Congenital heart diseases in children with Noonan syndrome: An expanded cardiac spectrum with high prevalence of atrioventricular canal. Journal of Pediatrics 1999, 135:703-706.
112. Martin D.M., Sheldon S., Gorski J.L. CHARGE association with choanal atresia and inner ear hypoplasia in a child with a de novo chromosome translocation t(2;7)(p14;q21.11). American Journal of Medical Genetics 2001, 99:115-119.
113. Martinelli S., Torreri P., Tinti M., Stella L., Bocchinfuso G., Flex E., Grottesi A., Ceccarini M., Palleschi A., Cesareni G., Castagnoli L., Petrucci T.C., Gelb B.D., Tartaglia M. Diverse driving forces underlie the invariant occurrence of the T42A, E139D, I282V and T468M SHP2 amino acid substitutions causing Noonan and LEOPARD syndromes. Human Molecular Genetics 2008, 17:2018-2029.
114. Mathieu M., Bourges E., Caron F., Piussan C. [Waardenburg's syndrome and severe cyanotic cardiopathy]. Archives of Francaise de Pediatrics 1990, 47:657-659.
115. McElhinney D.B., Krantz I.D., Bason L., Piccoli D.A., Emerick K.M., Spinner N.B., Goldmuntz E. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation 2002, 106:2567-2574.
116. McQuade L., Christodoulou J., Budarf M., Sachdev R., Wilson M., Emanuel B., Colley A. Patient with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR). American Journal of Medical Genetics 1999, 86:27-33.
117. Meadows S.M., Fletcher P.J., Moran C., Xu K., Neufeld G., Chauvet S., Mann F., Krieg P.A., Cleaver O. Integration of repulsive guidance cues generates avascular zones that shape Mammalian blood vessels. Circulation Research 2012, 110:34-46.
118. Mears A.J., Jordan T., Mirzayans F., Dubois S., Kume T., Parlee M., Ritch R., Koop B., Kuo W.L., Collins C., Marshall J., Gould D.B., Pearce W., Carlsson P., Enerbäck S., Morissette J., Bhattacharya S., Hogan B., Raymond V., Walter M.A. Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly. American Journal of Human Genetics 1998, 63:1316-1328.
119. Merscher S., Funke B., Epstein J.A., Heyer J., Puech A., Lu M.M., Xavier R.J., Demay M.B., Russell R.G., Factor S., Tokooya K., Jore B.S., Lopez M., Pandita R.K., Lia M., Carrion D., Xu H., Schorle H., Kobler J.B., Scambler P., Wynshaw-Boris A., Skoultchi A.I., Morrow B.E., Kucherlapati R. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 2001, 104:619-629.
120. Mesbah K., Harrelson Z., Théveniau-Ruissy M., Papaioannou V.E., Kelly R.G. Tbx3 is required for outflow tract development. Circulation Research 2008, 103:743-750.
121. Mesbah K., Rana M.S., Francou A., van Duijvenboden K., Papaioannou V.E., Moorman A.F., Kelly R.G., Christoffels V.M. Identification of a Tbx1/Tbx2/Tbx3 genetic pathway governing pharyngeal and arterial pole morphogenesis. Human molecular genetics 2011.
122. Miquerol L., Beyer S., Kelly R.G. Establishment of the mouse ventricular conduction system. Cardiovascular Research 2011, 91:232-242.
123. Molin D.G., Poelmann R.E., DeRuiter M.C., Azhar M., Doetschman T., Gittenberger-de Groot A.C. Transforming growth factor beta-SMAD2 signaling regulates aortic arch innervation and development. Circulation Research 2004, 95:1109-1117.
124. Moon A.M., Guris D.L., Seo J.-h., Li L., Hammond J., Talbot A., Imamoto A. Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes. Developmental cell 2006, 10:71-80.
125. Mulder G.B., Manley N., Grant J., Schmidt K., Zeng W., Eckhoff C., Maggio-Price L. Effects of excess vitamin A on development of cranial neural crest-derived structures: a neonatal and embryologic study. Teratology 2000, 62:214-226.
126. Nakamura T., Colbert M.C., Robbins J. Neural crest cells retain multipotential characteristics in the developing valves and label the cardiac conduction system. Circulation Research 2006, 98:1547-1554.
127. Nakamura T., Gulick J., Colbert M.C., Robbins J. Protein tyrosine phosphatase activity in the neural crest is essential for normal heart and skull development. Proceedings of the National academy of Sciences of the United States of America 2009, 106:11270-11275.
128. Newbern J., Zhong J., Wickramasinghe R.S., Li X., Wu Y., Samuels I., Cherosky N., Karlo J.C., O'Loughlin B., Wikenheiser J., Gargesha M., Doughman Y.Q., Charron J., Ginty D.D., Watanabe M., Saitta S.C., Snider W.D., Landreth G.E. Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development. Proceedings of the National academy of Sciences of the United States of America 2008, 105:17115-17120.
129. Niederreither K., Vermot J., Messaddeq N., Schuhbaur B., Chambon P., Dolle P. Embryonic retinoic acid synthesis is essential for heart morphogenesis in the mouse. Development (Cambridge, England) 2001, 128:1019-1031.
130. Nomura-Kitabayashi A., Phoon C.K.L., Kishigami S., Rosenthal J., Yamauchi Y., Abe K., Yamamura K.-i., Samtani R., Lo C.W., Mishina Y. Outflow tract cushions perform a critical valve-like function in the early embryonic heart requiring BMPRIA-mediated signaling in cardiac neural crest. American Journal of Physiology-Heart and Circulatory Physiology 2009, 297:H1617-H1628.
131. Nyquist-Battie C., Freter M. Cardiac mitochondrial abnormalities in a mouse model of the fetal alcohol syndrome. Alcoholism: Clinical & Experimental Research 1988, 12:264-267.
132. O'Donnell H., McKeown C., Gould C., Morrow B., Scambler P. Detection of an atypical 22q11 deletion that has no overlap with the DiGeorge syndrome critical region. American Journal of Human Genetics 1997, 60:1544-1548.
133. Oishi K., Gaengel K., Krishnamoorthy S., Kamiya K., Kim I.K., Ying H., Weber U., Perkins L.A., Tartaglia M., Mlodzik M., Pick L., Gelb B.D. Transgenic Drosophila models of Noonan syndrome causing PTPN11 gain-of-function mutations. Human molecular genetics 2006, 15:543-553.
134. Oishi K., Zhang H., Gault W.J., Wang C.J., Tan C.C., Kim I.-K., Ying H., Rahman T., Pica N., Tartaglia M., Mlodzik M., Gelb B.D. Phosphatase-defective LEOPARD syndrome mutations in PTPN11 gene have gain-of-function effects during Drosophila development. Human Molecular Genetics 2009, 18:193-201.
135. Olaopa M., Zhou H.-m., Snider P., Wang J., Schwartz R.J., Moon A.M., Conway S.J. Pax3 is essential for normal cardiac neural crest morphogenesis but is not required during migration nor outflow tract septation. Developmental Biology 2011, 356:308-322.
136. Pan J., Baker K.M. Retinoic acid and the heart. Vitam Horm 2007, 75:257-283.
137. Pandit B., Sarkozy A., Pennacchio L.A., Carta C., Oishi K., Martinelli S., Pogna E.A., Schackwitz W., Ustaszewska A., Landstrom A., Bos J.M., Ommen S.R., Esposito G., Lepri F., Faul C., Mundel P., López Siguero J.P., Tenconi R., Selicorni A., Rossi C., Mazzanti L., Torrente I., Marino B., Digilio M.C., Zampino G., Ackerman M.J., Dallapiccola B., Tartaglia M., Gelb B.D. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nature Genetics 2007, 39:1007-1012.
138. Park E.J., Ogden L.A., Talbot A., Evans S., Cai C.-L., Black B.L., Frank D.U., Moon A.M. Required, tissue-specific roles for Fgf8 in outflow tract formation and remodeling. Development (Cambridge, England) 2006, 133:2419-2433.
139. Park E.J., Watanabe Y., Smyth G., Miyagawa-Tomita S., Meyers E., Klingensmith J., Camenisch T., Buckingham M., Moon A.M. An FGF autocrine loop initiated in second heart field mesoderm regulates morphogenesis at the arterial pole of the heart. Development (Cambridge, England) 2008, 135:3599-3610.
140. Pasutto F., Sticht H., Hammersen G., Gillessen-Kaesbach G., Fitzpatrick D.R., Nürnberg G., Brasch F., Schirmer-Zimmermann H., Tolmie J.L., Chitayat D., Houge G., Fernández-Martínez L., Keating S., Mortier G., Hennekam R.C.M., von der Wense A., Slavotinek A., Meinecke P., Bitoun P., Becker C., Nürnberg P., Reis A., Rauch A. Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation. American Journal of Human Genetics 2007, 80:550-560.
141. Pavan M., Ruiz V.F., Silva F.A., Sobreira T.J., Cravo R.M., Vasconcelos M., Marques L.P., Mesquita S.M.F., Krieger J.E., Lopes A.A.B., Oliveira P.S., Pereira A.C., Xavier-Neto J. ALDH1A2 (RALDH2) genetic variation in human congenital heart disease. Bmc Med Genet 2009, 10:113.
142. Pingault V., Ente D., Dastot-Le Moal F., Goossens M., Marlin S., Bondurand N. Review and update of mutations causing Waardenburg syndrome. Hum Mutat 2010, 31:391-406.
143. Poelmann R.E., Gittenberger-de Groot A.C. A subpopulation of apoptosis-prone cardiac neural crest cells targets to the venous pole: multiple functions in heart development?. Developmental Biology 1999, 207:271-286.
144. Poelmann R.E., Mikawa T., Gittenberger-de Groot A.C. Neural crest cells in outflow tract septation of the embryonic chicken heart: differentiation and apoptosis. Developmental dynamics: an official publication of the American Association of Anatomists 1998, 212:373-384.
145. Poelmann R.E., Jongbloed M.R.M., Molin D.G.M., Fekkes M.L., Wang Z., Fishman G.I., Doetschman T., Azhar M., Gittenberger-de Groot A.C. The neural crest is contiguous with the cardiac conduction system in the mouse embryo: a role in induction?. Anat Embryol 2004, 208:389-393.
146. Porras D., Brown C.B. Temporal-spatial ablation of neural crest in the mouse results in cardiovascular defects. Developmental Dynamics: an Official Publication of the American Association of Anatomists 2008, 237:153-162.
147. Prescott K., Woodfine K., Stubbs P., Super M., Kerr B., Palmer R., Carter N.P., Scambler P. A novel 5q11.2 deletion detected by microarray comparative genomic hybridisation in a child referred as a case of suspected 22q11 deletion syndrome. Human Genetics 2005, 116:83-90.
148. Randall V., McCue K., Roberts C., Kyriakopoulou V., Beddow S., Barrett A.N., Vitelli F., Prescott K., Shaw-Smith C., Devriendt K., Bosman E., Steffes G., Steel K.P., Simrick S., Basson M.A., Illingworth E., Scambler P.J. Great vessel development requires biallelic expression of Chd7 and Tbx1 in pharyngeal ectoderm in mice. The Journal of Clinical Investigation 2009, 119:3301-3310.
149. Roberts C., Daw S.C., Halford S., Scambler P.J. Cloning and developmental expression analysis of chick Hira (Chira), a candidate gene for DiGeorge syndrome. Human molecular genetics 1997, 6:237-245.
150. Roberts C., Ivins S., Cook A.C., Baldini A., Scambler P.J. Cyp26 genes a1, b1 and c1 are down-regulated in Tbx1 null mice and inhibition of Cyp26 enzyme function produces a phenocopy of DiGeorge Syndrome in the chick. Human molecular genetics 2006, 15:3394-3410.
151. Roberts C., Sutherland H.F., Farmer H., Kimber W., Halford S., Carey A., Brickman J.M., Wynshaw-Boris A., Scambler P.J. Targeted mutagenesis of the Hira gene results in gastrulation defects and patterning abnormalities of mesoendodermal derivatives prior to early embryonic lethality. Molecular and Cell Biology 2002, 22:2318-2328.
152. Rothman K.J., Moore L.L., Singer M.R., Nguyen U.S., Mannino S., Milunsky A. Teratogenicity of high vitamin A intake. N Engl J Med 1995, 333:1369-1373.
153. Ryckebusch L., Wang Z., Bertrand N., Lin S.C., Chi X., Schwartz R., Zaffran S., Niederreither K. Retinoic acid deficiency alters second heart field formation. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:2913-2918.
154. Sarkozy A., Carta C., Moretti S., Zampino G., Digilio M.C., Pantaleoni F., Scioletti A.P., Esposito G., Cordeddu V., Lepri F., Petrangeli V., Dentici M.L., Mancini G.M.S., Selicorni A., Rossi C., Mazzanti L., Marino B., Ferrero G.B., Silengo M.C., Memo L., Stanzial F., Faravelli F., Stuppia L., Puxeddu E., Gelb B.D., Dallapiccola B., Tartaglia M. Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. Hum Mutat 2009, 30:695-702.
155. Satiroglu-Tufan N.L., Tufan A.C. Amelioration of ethanol-induced growth retardation by all-trans-retinoic acid and alpha-tocopherol in shell-less culture of the chick embryo. Reprod Toxicol 2004, 18:407-412.
156. Sato A., Scholl A.M., Kuhn E.B., Stadt H.A., Decker J.R., Pegram K., Hutson M.R., Kirby M.L. FGF8 signaling is chemotactic for cardiac neural crest cells. Developmental Biology 2011, 354:18-30.
157. Scambler P.J. The 22q11 deletion syndromes. Human molecular genetics 2000, 9:2421-2426.
158. Scambler P.J. 22q11 deletion syndrome: a role for TBX1 in pharyngeal and cardiovascular development. Pediatrics Cardiology 2010, 31:378-390.
159. Seitz H., Zamore P.D. Rethinking the microprocessor. Cell 2006, 125:827-829.
160. Seo J.-h., Suenaga A., Hatakeyama M., Taiji M., Imamoto A. Structural and functional basis of a role for CRKL in a fibroblast growth factor 8-induced feed-forward loop. Molecular and Cell Biology 2009, 29:3076-3087.
161. Seo S., Kume T. Forkhead transcription factors, Foxc1 and Foxc2, are required for the morphogenesis of the cardiac outflow tract. Developmental Biology 296 2006, 421-436.
162. Shiohama A., Sasaki T., Noda S., Minoshima S., Shimizu N. Molecular cloning and expression analysis of a novel gene DGCR8 located in the DiGeorge syndrome chromosomal region. Biochemical and Biophysical Research Communications 2003, 304:184-190.
163. Shprintzen R.J. Velo-cardio-facial syndrome: 30 Years of study. Developmental Disabilities Research Reviews 2008, 14:3-10.
164. Siebert J.R., Graham J.M., MacDonald C. Pathologic features of the CHARGE association: support for involvement of the neural crest. Teratology 1985, 31:331-336.
165. Singh S.M., Murphy B., O'Reilly R. Monozygotic twins with chromosome 22q11 deletion and discordant phenotypes: updates with an epigenetic hypothesis. Journal of Medical Genetics 2002, 39:e71.
166. Amand T.R., Lu J.T., Zamora M., Gu Y., Stricker J., Hoshijima M., Epstein J.A., Ross J.J., Ruiz-Lozano P., Chien K.R. Distinct roles of HF-1b/Sp4 in ventricular and neural crest cells lineages affect cardiac conduction system development. Developmental Biology 2006, 291:208-217. St.
167. Staiano A., Santoro L., De Marco R., Miele E., Fiorillo F., Auricchio A., Carpentieri M.L., Celli J., Auricchio S. Autonomic dysfunction in children with Hirschsprung's disease. Dig Dis Sci 1999, 44:960-965.
168. Stalmans I., Lambrechts D., De Smet F., Jansen S., Wang J., Maity S., Kneer P., von der Ohe M., Swillen A., Maes C., Gewillig M., Molin D.G.M., Hellings P., Boetel T., Haardt M., Compernolle V., Dewerchin M., Plaisance S., Vlietinck R., Emanuel B., Gittenberger-de Groot A.C., Scambler P., Morrow B., Driscol D.A., Moons L., Esguerra C.V., Carmeliet G., Behn-Krappa A., Devriendt K., Collen D., Conway S.J., Carmeliet P. VEGF: a modifier of the del22q11 (DiGeorge) syndrome?. Nat Med 2003, 9:173-182.
169. Stewart R.A., Sanda T., Widlund H.R., Zhu S., Swanson K.D., Hurley A.D., Bentires-Alj M., Fisher D.E., Kontaridis M.I., Look A.T., Neel B.G. Phosphatase-dependent and -independent functions of Shp2 in neural crest cells underlie LEOPARD syndrome pathogenesis. Developmental Cell 2010, 18:750-762.
170. Stottmann R.W., Choi M., Mishina Y., Meyers E.N., Klingensmith J. BMP receptor IA is required in mammalian neural crest cells for development of the cardiac outflow tract and ventricular myocardium. Development (Cambridge, England) 2004, 131:2205-2218.
171. Sulik K.K., Johnston M.C., Daft P.A., Russell W.E., Dehart D.B. Fetal alcohol syndrome and DiGeorge anomaly: critical ethanol exposure periods for craniofacial malformations as illustrated in an animal model. American Journal of Medical Genetics Supplement 1986, 2:97-112.
172. Tang S., Snider P., Firulli A.B., Conway S.J. Trigenic neural crest-restricted Smad7 over-expression results in congenital craniofacial and cardiovascular defects. Developmental Biology 2010, 344:233-247.
173. Tartaglia M., Gelb B.D., Zenker M. Noonan syndrome and clinically related disorders. Best Practice & Research: Clinical & Endocrinology Metabolism 2011, 25:161-179.
174. Tartaglia M., Kalidas K., Shaw A., Song X., Musat D.L., van der Burgt I., Brunner H.G., Bertola D.R., Crosby A., Ion A., Kucherlapati R.S., Jeffery S., Patton M.A., Gelb B.D. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. American Journal of Human Genetics 2002, 70:1555-1563.
175. Tartaglia M., Martinelli S., Stella L., Bocchinfuso G., Flex E., Cordeddu V., Zampino G., Burgt I., Palleschi A., Petrucci T.C., Sorcini M., Schoch C., Foa R., Emanuel P.D., Gelb B.D. Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. American Journal of Human Genetics 2006, 78:279-290.
176. Tassabehji M., Newton V.E., Leverton K., Turnbull K., Seemanova E., Kunze J., Sperling K., Strachan T., Read A.P. PAX3 gene structure and mutations: close analogies between Waardenburg syndrome and the Splotch mouse. Human molecular genetics 1994, 3:1069-1074.
177. Turnpenny, P.D., Ellard, S., 2011. Alagille syndrome: pathogenesis, diagnosis and management. European Journal of Human Genetics.
178. Tzahor E., Evans S.M. Pharyngeal mesoderm development during embryogenesis: implications for both heart and head myogenesis. Cardiovascular Research 2011, 91:196-202.
179. van Bueren K.L., Papangeli I., Rochais F., Pearce K., Roberts C., Calmont A., Szumska D., Kelly R.G., Bhattacharya S., Scambler P.J. Hes1 expression is reduced in Tbx1 null cells and is required for the development of structures affected in 22q11 deletion syndrome. Developmental Biology 2010, 340:369-380.
180. van den Hoff M.J., Moorman A.F., Ruijter J.M., Lamers W.H., Bennington R.W., Markwald R.R., Wessels A. Myocardialization of the cardiac outflow tract. Developmental Biology 1999, 212:477-490.
181. Vitelli F., Morishima M., Taddei I., Lindsay E.A., Baldini A. Tbx1 mutation causes multiple cardiovascular defects and disrupts neural crest and cranial nerve migratory pathways. Human Molecular Genetics 2002, 11:915-922.
182. Vitelli F., Taddei I., Morishima M., Meyers E.N., Lindsay E.A., Baldini A. A genetic link between Tbx1 and fibroblast growth factor signaling. Development (Cambridge, England) 2002, 129:4605-4611.
183. Vitelli F., Lania G., Huynh T., Baldini A. Partial rescue of the Tbx1 mutant heart phenotype by Fgf8: genetic evidence of impaired tissue response to Fgf8. Journal of Molecular Cell Cardiology 2010, 49:836-840.
184. Waldo K., Miyagawa-Tomita S., Kumiski D., Kirby M.L. Cardiac neural crest cells provide new insight into septation of the cardiac outflow tract: aortic sac to ventricular septal closure. Developmental Biology 196 1998, 129-144.
185. Waldo K.L., Hutson M.R., Stadt H.A., Zdanowicz M., Zdanowicz J., Kirby M.L. Cardiac neural crest is necessary for normal addition of the myocardium to the arterial pole from the secondary heart field. Developmental Biology 2005, 281:66-77.
186. Waldo K.L., Lo C.W., Kirby M.L. Connexin 43 expression reflects neural crest patterns during cardiovascular development. Developmental Biology 1999, 208:307-323.
187. Ward C., Stadt H., Hutson M., Kirby M.L. Ablation of the secondary heart field leads to tetralogy of Fallot and pulmonary atresia. Developmental Biology 284 2005, 72-83.
188. Watanabe Y., Miyagawa-Tomita S., Vincent S.D., Kelly R.G., Moon A.M., Buckingham M.E. Role of mesodermal FGF8 and FGF10 overlaps in the development of the arterial pole of the heart and pharyngeal arch arteries. Circulation Research 2010, 106:495-503.
189. Wentzel P., Eriksson U.J. Altered gene expression in neural crest cells exposed to ethanol in vitro. Brain Research 2009, 1305. Suppl, S50-60.
190. Wilson J.G., Roth C.B., Warkany J. An analysis of the syndrome of malformations induced by maternal vitamin A deficiency. Effects of restoration of vitamin A at various times during gestation. The American Journal of Anatomy 1953, 92:189-217.
191. Wilson J.G., Warkany J. Congenital anomalies of heart and great vessels in offspring of vitamin A-deficient rats. American Journal of Diseases of Children 1950, 79:963.
192. Winnier G.E., Kume T., Deng K., Rogers R., Bundy J., Raines C., Walter M.A., Hogan B.L., Conway S.J. Roles for the winged helix transcription factors MF1 and MFH1 in cardiovascular development revealed by nonallelic noncomplementation of null alleles. Developmental Biology 1999, 213:418-431.
193. Xu H., Morishima M., Wylie J.N., Schwartz R.J., Bruneau B.G., Lindsay E.A., Baldini A. Tbx1 has a dual role in the morphogenesis of the cardiac outflow tract. Development (Cambridge, England) 2004, 131:3217-3227.
194. Yanagisawa H., Hammer R.E., Richardson J.A., Williams S.C., Clouthier D.E., Yanagisawa M. Role of Endothelin-1/Endothelin-A receptor-mediated signaling pathway in the aortic arch patterning in mice. Journal of Clinical Investigation 1998, 102:22-33.
195. Yelbuz T.M., Waldo K.L., Kumiski D.H., Stadt H.A., Wolfe R.R., Leatherbury L., Kirby M.L. Shortened outflow tract leads to altered cardiac looping after neural crest ablation. Circulation 2002, 106:504-510.
196. Yelin R., Schyr R.B.-H., Kot H., Zins S., Frumkin A., Pillemer G., Fainsod A. Ethanol exposure affects gene expression in the embryonic organizer and reduces retinoic acid levels. Developmental Biology 2005, 279:193-204.
197. Yu H.H., Kolodkin A.L. Semaphorin signaling: a little less per-plexin. Neuron 1999, 22:11-14.
198. Zenker M., Buheitel G., Rauch R., Koenig R., Bosse K., Kress W., Tietze H.-U., Doerr H.-G., Hofbeck M., Singer H., Reis A., Rauch A. Genotype-phenotype correlations in Noonan syndrome. Journal of Pediatrics 2004, 144:368-374.
199. Zhang Z., Baldini A. In vivo response to high-resolution variation of Tbx1 mRNA dosage. Human Molecular Genetics 2008, 17:150-157.
200. Zhang Z., Cerrato F., Xu H., Vitelli F., Morishima M., Vincentz J., Furuta Y., Ma L., Martin J., Baldini A., Lindsay E. Tbx1 expression in pharyngeal epithelia is necessary for pharyngeal arch artery development. Development (Cambridge, England) 2005, 132:5307-5315.
201. Zile M.H. Function of vitamin A in vertebrate embryonic development. Journal of Nutrition 2001, 131:705-708.